Publication | Closed Access

Screening of commercial cyclic peptide conjugated to HIV-1 Tat peptide as inhibitor of N-terminal heptad repeat glycoprotein-2 ectodomain Ebola virus through in silico analysis

Silico AnalysisHuman RetrovirusImmunologyAntiviral ResponseAntiviral Drug DevelopmentVirologyAntiviral TherapyHiv-1 Tat PeptideAntiviral DrugHivMedicine